Quantitative temporal and spatial distribution of adenovirus type 2 correlates with disease manifestations and organ failure during disseminated infection

Journal of Medical Virology

Volumn 80, Issue 2, 2008, Pages 294-297

  Forstmeyer, Dirk ^a   Henke Gendo, Cornelia ^a   Bröcker, Verena ^a   Wildner, Oliver ^b   Heim, Albert ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS   (Germany)

Author keywords

Adenovirus; Disseminated infection; Liver failure; Pathogenesis; Quantitative PCR

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CORTICOSTEROID; CYCLOSPORIN A; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MELPHALAN; METHOTREXATE; PREDNISONE; RAPAMYCIN; RIBAVIRIN; THYMOCYTE ANTIBODY; VIRUS DNA;

ADENOVIRUS 2; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; COLON BIOPSY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HUMAN; LIVER; LIVER FAILURE; LUNG; LYMPHOMA; MALE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TYPING;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADULT; BONE MARROW; COLON; DIARRHEA; DNA, VIRAL; HUMANS; LIVER; MALE; MULTIPLE ORGAN FAILURE; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VIRAL LOAD; VIREMIA;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 2;

EID: 37549060018     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21071     Document Type: Article

References (14)

1. Chakrabarti S, Collingham KE, Fegan CD, Milligan DW. 1999. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: Failure of intravenous ribavirin therapy. Bone Marrow Transplant 23:1209-1211.
2. Chakrabarti S, Mautner V, Osman H, Collingham KE, Fegan CD, Klapper PE, Moss PA, Milligan DW. 2002. Adenovirus infections following allogeneic stem cell transplantation: Incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100:1619-1627.
3. Cichon G, Boeckh-Herwig S, Schmidt HH, Wehnes E, Muller T, Pring-Akerblom P, Burger R. 2001. Complement activation by recombinant adenoviruses. Gene Ther 8:1794-1800.
4. Garnett CT, Erdman D, Xu W, Gooding LR. 2002. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol 76:10608-10616.
5. Hale GA, Heslop HE, Krance RA, Brenner MA, Jayawardene D, Srivastava DK, Patrick CC. 1999. Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant 23:277-282.
6. Heim A, Ebnet C, Harste G, Pring-Akerblom P. 2003. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 70:228-239.
7. Kampmann B, Cubitt D, Walls T, Naik P, Depala M, Samarasinghe S, Robson D, Hassan A, Rao K, Gaspar H, Davies G, Jones A, Cale C, Gilmour K, Real M, Foo M, Bennett-Rees N, Hewitt A, Amrolia P, Veys P. 2005. Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol 130:595-603.
8. Madisch I, Wolfel R, Harste G, Pommer H, Heim A. 2006. Molecular identification of adenovirus sequences: A rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients. J Med Virol 78:1210-1217.
9. Myers GD, Bollard CM, Wu MF, Weiss H, Rooney CM, Heslop HE, Leen AM. 2007. Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 39:677-686.
10. Nakazawa H, Ito T, Makishima H, Misawa N, Okiyama W, Uehara T, Hidaka E, Kiyosawa K, Ishida F. 2006. Adenovirus fulminant hepatic failure: Disseminated adenovirus disease after unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia. Intern Med 45:975-980.
11. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, Wilson JM, Batshaw ML. 2003. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148-158.
12. Seidemann K, Heim A, Pfister ED, Koditz H, Beilken A, Sander A, Melter M, Sykora KW, Sasse M, Wessel A. 2004. Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: Report of six cases and review of the literature. Am J Transplant 4:2102-2108.
13. Stone D, Liu Y, Shayakhmetov D, Li ZY, Ni S, Lieber A. 2007. Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol 81:4866-4871.
14. Wandinger K, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H, Wessel K, Kirchner H, Hennig H. 2000. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55:178-184.